If you want a Stock Review on SGYP, NVO, UTHR, or DEPO then come over to http://dailystocktracker.com/register/ …
stock is biggest percentage decliner in S&P 1500 healthcare sector and on track for worst one-day drop since Feb ** Co said late on Thurs that an independent monitoring committee said pulmonary arterial hypertension study involving …
For a hedged play on United Therapeutics (UTHR), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Dec 15, 2017 $120 covered call for a net debit in the $116.42 area. That is also the break-even stock
A federal appeals court has affirmed an earlier ruling by the Patient Trial and …
Let's see if United Therapeutics Corporation (UTHR) stock is a good choice for value-oriented investors right now from multiple angles. Let's see if United Therapeutics Corporation (UTHR) ...
The biotechnology sector entered a bear market at the start of 2016, knocking sector funds and indices to 18-month lows. The group has bounced since mid-February, but its performance has lagged broad benchmarks including the SP-500 …
Shares are up after Jim Cramer spoke favorable of the stock on his “Mad Money” TV show. United Therapeutics Corporation (NASDAQ: UTHR) is down roughly 6% premarket to $58.90, relative to a 52-week range of $46.14-$70.74. …
CINCINNATI (MarketWatch) — On a near-term basis, the major U.S. stock benchmarks have virtually flatlined. Nonetheless, the recent “flatness” points to a technically constructive longer-term backdrop ... Therapeutics Corp. …
The Massachusetts-based medical implant device maker’s stock returned 17.7% during the third quarter. ABIOMED, …